Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SR One

SR One
VC INVESTOR TYPE
Active STATUS
7 PROFESSIONALS
201 INVESTMENTS
38 PORTFOLIO
106 EXITS
Description

Founded in 1985, SR One is the corporate venture capital arm of GlaxoSmithKline based in Cambridge, Massachusetts. The firm prefers to invest in the life science, biotechnology, healthcare, medical devices, and information technology sectors. The firm has additional offices in Conshohocken, London, and San Francisco.

Website
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1985
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Accelerator/Incubator
Venture Capital
Primary Office
  • One Broadway
  • Cambridge, MA 02142
  • United States

SR One Investments (201)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Arcellx 14-Oct-2019 Early Stage VC 0000 Biotechnology Pre-Clinical Trials
0000000 07-Oct-2019 00000 00000 000.00 Biotechnology Startup 0000000 0000000 00.0
000000 00000000000 04-Sep-2019 00000 00000 00000 Biotechnology Generating Revenue 0000 0000000
00000000 000000000 13-May-2019 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 000000 000000 00
0000 000 30-Apr-2019 00000 00000 0000 Biotechnology Clinical Trials - General 0000000 000
00000000 000000000 01-Jan-2019 00000 00000 Other Healthcare Services Stealth
0000000 00000 0000 19-Oct-2018 000000000 0000 Biotechnology Clinical Trials - General 000000 000000 00
000000 00000000000 10-Oct-2018 00000 00000 0000 Drug Discovery Startup 0000 0000000
Morphic Therapeutic 25-Sep-2018 Early Stage VC 0000 Drug Discovery Generating Revenue/Not Profitable 00000 00000
Decibel Therapeutics 19-Jun-2018 Later Stage VC 000.00 Biotechnology Clinical Trials - Phase 1 0000 00000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SR One’s full profile, request a free trial.

SR One Exits (106)

Company Name Exit Date Exit Type Exit Size Status Buyers
Progyny 25-Oct-2019 IPO 00000 Completed
000000000 000 18-Sep-2019 000000 0000000000 0000 Completed
0000000 0000000000 27-Jun-2019 000 0000 Completed
000000 13-Jun-2019 000000000000000000 Completed
  • 0000000000 0000000
0000000 0000000000 23-May-2019 000 000.00 Completed
0000000 00000 0000 17-Apr-2019 000 00000 Completed
000000000 000000 06-Jan-2019 000000000000000000 00000 Completed
  • 000000
000000000 00000000 14-Sep-2018 000 00000 Completed
  • 000000000000000
Constellation Pharmaceuticals 19-Jul-2018 IPO 0000 Completed
Translate Bio 28-Jun-2018 IPO 00000 Completed
To view this investor’s complete exits history, request access »

SR One Team (17)

Name Title Deals Funds Boards Office Contact
Info
Simeon George MD Chief Executive Officer 00 0 0 San Francisco, CA
Deborah Harland Ph.D Partner 00 0 0 London, United Kingdom
Matthew Foy Partner 0 0 0 London, United Kingdom
Rajeev Dadoo Ph.D Partner 00 0 0 San Francisco, CA
Karen Engel Partner, Finance 0 0 Conshohocken, PA

10 Former Team Members

You’re viewing 5 of 17 team members. Get the full list »